Literature DB >> 12426309

Altered interactions between the A1 and A2 subunits of factor VIIIa following cleavage of A1 subunit by factor Xa.

Keiji Nogami1, Hironao Wakabayashi, Kyla Schmidt, Philip J Fay.   

Abstract

Factor VIIIa consists of subunits designated A1, A2, and A3-C1-C2. The limited cofactor activity observed with the isolated A2 subunit is markedly enhanced by the A1 subunit. A truncated A1 (A1(336)) was previously shown to possess similar affinity for A2 and retain approximately 60% of its A2 stimulatory activity. We now identify a second site in A1 at Lys(36) that is cleaved by factor Xa. A1 truncated at both cleavage sites (A1(37-336)) showed little if any affinity for A2 (K(d)>2 microm), whereas factor VIIIa reconstituted with A2 plus A1(37-336)/A3-C1-C2 dimer demonstrated significant cofactor activity ( approximately 30% that of factor VIIIa reconstituted with native A1) in a factor Xa generation assay. These affinity values were consistent with values obtained by fluorescence energy transfer using acrylodan-labeled A2 and fluorescein-labeled A1. In contrast, factor VIIIa reconstituted with A1(37-336) showed little activity in a one-stage clotting assay. This resulted in part from a 5-fold increase in K(m) for factor X when A1 was cleaved at Arg(336). These findings suggest that both A1 termini are necessary for functional interaction of A1 with A2. Furthermore, the C terminus of A1 contributes to the K(m) for factor X binding to factor Xase, and this parameter is critical for activity assessed in plasma-based assays.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426309     DOI: 10.1074/jbc.M209811200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Identification of residues contributing to A2 domain-dependent structural stability in factor VIII and factor VIIIa.

Authors:  Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

2.  Use of affinity-directed liquid chromatography-mass spectrometry to map the epitopes of a factor VIII inhibitor antibody fraction.

Authors:  A E Griffiths; W Wang; F K Hagen; P J Fay
Journal:  J Thromb Haemost       Date:  2011-08       Impact factor: 5.824

3.  Role of P1 residues Arg336 and Arg562 in the activated-Protein-C-catalysed inactivation of Factor VIIIa.

Authors:  Fatbardha Varfaj; Julie Neuberg; P Vincent Jenkins; Hironao Wakabayashi; Philip J Fay
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

4.  Sequences flanking Arg336 in factor VIIIa modulate factor Xa-catalyzed cleavage rates at this site and cofactor function.

Authors:  Jennifer P DeAngelis; Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2012-03-12       Impact factor: 5.157

5.  Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study.

Authors:  Divi Venkateswarlu
Journal:  BMC Struct Biol       Date:  2010-02-25

Review 6.  The molecular basis of factor V and VIII procofactor activation.

Authors:  R M Camire; M H A Bos
Journal:  J Thromb Haemost       Date:  2009-09-18       Impact factor: 5.824

7.  Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor V.

Authors:  Andrew J Gale; Thomas J Cramer; Diana Rozenshteyn; Jason R Cruz
Journal:  J Biol Chem       Date:  2008-04-18       Impact factor: 5.157

Review 8.  Factor VIII structure and function.

Authors:  Philip J Fay
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

9.  Identification of plasmin-interactive sites in the light chain of factor VIII responsible for proteolytic cleavage at Lys36.

Authors:  Keiji Nogami; Katsumi Nishiya; Evgueni L Saenko; Masahiro Takeyama; Kenichi Ogiwara; Akira Yoshioka; Midori Shima
Journal:  J Biol Chem       Date:  2009-01-06       Impact factor: 5.157

10.  Combining mutations that modulate inter-subunit interactions and proteolytic inactivation enhance the stability of factor VIIIa.

Authors:  H Wakabayashi; J M Wintermute; P J Fay
Journal:  Thromb Haemost       Date:  2014-03-06       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.